powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1174962146
Ghaith Abu Zeinah
M.D.
Medical Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
297
Beneficiaries
—
Total drug cost
$3.7M
Distinct drugs
6
Brand share
89.2%
Top prescribed drugs
Peginterferon Alfa-2a
92 claims
Ruxolitinib Phosphate
74 claims
Ropeginterferon Alfa-2b-Njft
47 claims
Hydroxyurea
32 claims
Momelotinib Dihydrochloride
28 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 330101
Hospital
CCN 330270
Hospital
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$5K
Payment records
3
By payment type
Consulting Fee
$4K
Food and Beverage
$229
Top paying entities
Consulting Fee
$4K
Food and Beverage
$229
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
211
Unique beneficiaries
—
Total services
486
Distinct HCPCS
5
Medicare payment
$48K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).
